missing translation for 'onlineSavingsMsg'
Learn More
Learn More
IBA Lifesciences pDSG-IBA Small Mammalian Expression Vector
Sfoglia Tutto IBA Lifesciences Prodotti

Click to view available options
Vettore:
pDSG-IBA102
pDSG-IBA103
pDSG-IBA104
pDSG-IBA105
pDSG-IBA43
pDSG-IBA45
pDSG-IBAwt1
pDSG-IBAwt2
Protein Tag:
His Tag (6x), Strep-tag II
Twin-Strep-tag
Untagged
Dimensione della confezione:
5µg
Descrizione
pDSG-IBA vectors for MEXi mammalian expression system
- Small transient expression vector especially developed for the use in combination with the MEXi mammalian expression system.
- Designed for high-level stable and non-replicative transient expression in most mammalian hosts containing the following elements:
- Human cytomegalovirus (CMV) immediate-early promoter for high-level expression in a wide range of mammalian cells
- Episomal replication through Epstein Barr Virus replication origin (oriP) requires chromosomally expressed nuclear antigen encoded by EBNA-1
- Ampicillin resistance and ColE1 replication origin (pUC) for propagation in E. coliin a high plasmid copy number
Please note that cloning into pDSG-IBA Acceptor Vectors compulsorily requires the restriction enzyme Esp3I since no other MCS for the integration of a gene of interest is available. In addition to the direct cloning of the gene of interest into pDSG-IBA vectors with Esp3I, another option via a so-called Entry-Vector is possible.
Specifica
Specifica
| Sistema costitutivo o inducibile | Constitutive |
| Gene marcatore | Ampicillin |
| Promotore | CMV |
| Product Type | Vector |
| Agente di selezione (eucariotico) | Geneticin™ (G-418) |
| Content And Storage | Recommended: 2°C to 8°C for frequent usage, -20°C for long-term storage |
| Specie | Mammalian |
| Protein Tag | Twin-Strep-tag |
| Cloning Method | Direct Cloning |
| Concentrazione | 250 ng/μL |
| Vedi altri risultati |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu